RB1 and retinoblastoma: Consistent with the oncogenic activity of PRC2 in RB, knockdown of suppressor of zeste 12 (SUZ12), another core subunit of PRC2, has been shown to inhibit RB cell invasion properties (Zhou, Sun, Liu, & Ma, 2014).